Chinese herbal medicine for curing chronic or intractable immune thrombocytopenia and preparation method of Chinese medicine preparation

Abstract

The invention discloses Chinese herbal medicine for curing chronic or intractable immune thrombocytopenia and a preparation method of Chinese medicine preparation. The Chinese herbal medicine consists of the following raw materials by weight: 1 to 100 parts of radix pseudostellariae, 1 to 98 parts of fried atractylodes, 1 to 100 parts of glabrous greenbrier rhizome, 1 to 98 parts of baked licorice, 1 to 98 parts of cinnamon twig, 1 to 98 parts of radix paeoniae alba, 1 to 98 parts of cynomorium, 1 to 98 parts of epimedium, 1 to 98 parts of poison yam, 1 to 98 parts of dioscorea, 1 to 98 parts of flos lonicerae, 1 to 98 parts of herba taraxaci, 1 to 98 parts of ginger and 1 to 98 parts of jujube. The preparation method of the Chinese medicine preparation comprises the following steps that: (1) weighing the raw materials according to the compositions of the Chinese herbal medicine; and (2) placing the raw materials into a pot, filling water into the pot to immerse the herbs, starting steam to steam the herbs for two times, filtering the medicine lotion, and mixing the filtered medicine lotion. Due to the adoption of the Chinese herbal medicine, the efficacy on clinically curing chronic immune thrombocytopenia (cITP) patients or intractable immune thrombocytopenia (rITP) patients can be improved, and the abnormal immune state of the cITP patients or rITP patients can be effectively adjusted.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating chronic or refractory immune thrombocytopenia and a preparation method of a traditional Chinese medicine preparation. Background technique [0002] Thrombocytopenia was formerly known as "idiopathic thrombocytopenic purpura (ITP)", ITP is an acquired autoimmune disease, which is thrombocytopenia caused by immune dysfunction; immune diseases", the exact mechanism that causes ITP is unclear. In 2007, the ITP International Working Group (IWG) recommended renaming idiopathic thrombocytopenic purpura as "Immune thrombocytopenia (ITP)", and recommended the use of "Immune" (Immune) to emphasize The onset is mediated by immunity; in addition, because a considerable number of patients have no or only minor bleeding symptoms, "purpura" is no longer used; the abbreviation is still written as ITP. According to the clinical manifestations of ITP, the duration of thrombocytopenia and the therapeu...

AI Technical Summary

Problems solved by technology

But at present, there are the following technical defects in the treatment of ITP by traditional Chinese medicine: 1. The clinical curative effect is not significant enough: the number of platelets is not significantly increased, and the effective rate of ITP patients is low; The disordered immune status tends to be normal; 3. The curative effect on cITP patients or rITP patients is not significant

Images